Holen Sie sich die Stockscreener-App
4.35
15.38%
0.58
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SLS?
Forum
Prognose
Aktiensplit
Sellas Life Sciences Group Inc Aktie (SLS) Neueste Nachrichten
Ironwood Pharmaceuticals, Baidu, Vertiv Holdings And Other Big Stocks Moving Higher On Friday - Benzinga
Why Is SLS Stock Drawing Significant Investor Attention Today? - Stocktwits
SELLAS Life Sciences Group Stock (SLS) Opinions on Phase 3 Trial Progress - Quiver Quantitative
SELLAS Life Sciences Group stock soars as it nears final analysis in cancer study - MSN
Weekly Buzz: ARS Pharma's Neffy Goes East, SLS Advances, A Signal Of Hope For IFRX? - RTTNews
SELLAS (SLS) stock jumps about 10% in premarket as REGAL AML trial milestone stays in focus - ts2.tech
Promising Penny Stocks To Add to Your WatchlistJanuary 1st - MarketBeat
Sellas Life Sciences Showcases Promising Phase 2 Data at Annual Meeting - StocksToTrade
Sellas Life Sciences Showcases Breakthroughs in AML Treatment - timothysykes.com
Axsome Therapeutics, Plug Power And Other Big Stocks Moving Higher On Wednesday - Benzinga
Largest borrow rate increases among liquid names - TipRanks
SELLAS Life Sciences Stock Surge: Buy or Wait? - StocksToTrade
SELLAS’s Therapy Triumph: Market Buzz - timothysykes.com
Discover the Top 5 Small-Cap Biotech Stocks in 2025 - Investing News Network
CapsoVision, ACM Research And Other Big Stocks Moving Higher On Tuesday - Benzinga
SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S in Acute Myeloid Leukemia - marketscreener.com
SELLAS Reports Continued Progress In Phase 3 REGAL Trial Of GPS In Acute Myeloid Leukemia - Nasdaq
SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next - ts2.tech
Sellas Life Sciences Stock Surges After Positive Clinical Trials - StocksToTrade
SELLAS Life Sciences Stock Is Surging Higher: What's Going On? - Benzinga
Sellas Life Sciences stock soars after trial update shows slower event rate By Investing.com - Investing.com Australia
Sellas Life Sciences stock soars after trial update shows slower event rate - Investing.com Canada
SELLAS Life Sciences (SLS) Stock: Shows Bullish Momentum Ahead of Pivotal AML Data Readout - parameter.io
SELLAS Life Sciences Group Stock Soars As It Nears Final Analysis In Cancer Study - Stocktwits
SLS Stocks Surge As New Phase 2 Results Show Promising Outcomes - timothysykes.com
Mereo BioPharma, Ultragenyx Pharmaceutical And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Sellas Life Sciences Says 72 Deaths Have Occurred in Phase 3 Acute Myeloid Leukemia Trial - marketscreener.com
Sellas Life Sciences says REGAL trial CRO informs company 72 events occurred - TipRanks
SELLAS reports 72 events in Phase 3 REGAL trial, awaits final analysis - Investing.com
Leukemia study awaits 80th death to trigger final analysis - Stock Titan
Why Vinci Partners Investments Ltd. stock remains undervaluedEarnings Growth Patterns & Affordable Portfolio Growth - bollywoodhelpline.com
Will TKNO stock benefit from upcoming earnings reportsTrend Following Strategies & Free Superior Profit Margins - bollywoodhelpline.com
Is It Too Late to Sell STEL Holdings LimitedGrowth Stock Opportunities & Small Capital Wealth Plans - bollywoodhelpline.com
How Is The Market Feeling About SELLAS Life Sciences Group Inc? - Benzinga
SELLAS Life Sciences (SLS) Is Up 34.6% After Leukemia Data Update Has The Bull Case Changed? - simplywall.st
Assessing SELLAS Life Sciences Group (SLS) Valuation After Positive Leukemia Data and Supportive FDA Designations - Yahoo Finance
SLS Stock Has Risen 78% In A Month — What’s The Retail Buzz About? - Stocktwits
SELLAS Surge: Analyzing the Latest Performance - StocksToTrade
SELLAS Life Sciences Soars: A Game-Changer? - timothysykes.com
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge - GlobeNewswire
SELLAS Life Sciences Group, Inc. Stock (SLS) Opinions on Clinical Trial Results - Quiver Quantitative
SELLAS Life Sciences (SLS) Stock Update: ASH 2025 Data, REGAL Trial Countdown, Analyst Targets, and Key Risks (Dec. 23, 2025) - ts2.tech
Sellas Life Sciences: Ready for a Breakthrough? - StocksToTrade
Sellas Life Sciences Nears Critical Inflection Point - AD HOC NEWS
Aug Drivers: Is SELLAS Life Sciences Group Inc RXK3 stock trading at attractive multiplesWeekly Trade Analysis & Consistent Return Strategy Ideas - moha.gov.vn
Jumping in during volatile news — sit outSell Signals and Alerts & Invest Smarter With Signals - Bollywood Helpline
What Wall Street predicts for SELLAS Life Sciences Group Inc. stock priceTreasury Yields & Daily Chart Pattern Signals - Улправда
Is SELLAS Life Sciences Group Inc. stock affected by interest rate hikes2025 Volume Leaders & Safe Entry Zone Tips - Улправда
Can SELLAS Life Sciences Group Inc. stock beat market expectations this quarterJuly 2025 Trade Ideas & Stepwise Trade Execution Plans - DonanımHaber
Why SELLAS Life Sciences Group Inc. stock could outperform in 2025July 2025 Outlook & Reliable Entry Point Alerts - DonanımHaber
Will SELLAS Life Sciences Group Inc. (RXK3) stock hit Wall Street targetsInflation Watch & Consistent Income Trade Recommendations - Улправда
Published on: 2025-12-19 12:18:55 - DonanımHaber
Sellas Life Sciences stock has doubled this year – here’s why retail investors are still bullish - MSN
Sellas Life Sciences Unveils Positive Phase 2 Results for SLS009 - StocksToTrade
Will SELLAS Life Sciences Group Inc. (RXK3) stock beat growth indexes2025 Volatility Report & Stepwise Trade Execution Plans - Улправда
SELLAS Life Sciences Stock Has Doubled This Year – Here’s Why Retail Investors Are Still Bullish - Stocktwits
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):